ANI Pharmaceuticals Corp (ANIP) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
ANI Pharmaceuticals ekotizimi nisha generiklarining moslanuvchan ishlab chiqarish orqali shifoxonalar va dorixonalarning barqaror ta'minotiga tayanadi. Ushbu narxlar grafigi hozirda 0.94 darajasida bo'lgan ko'rsatkichning tendentsiyasini aks ettiradi. Barqaror pul oqimi va kamyob dori vositalaridagi yuqori marjalar foydaning ishonchliligini kafolatlaydi, maxsus gellar va yangi mahsulot liniyalarining kengayishi esa kuchli o'sish impulsini yaratadi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_ANIP_-_ANI-Pharmaceuticals_-_Long-Term-Debt-to-Capital "ANIP: ANI Pharmaceuticals, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 30.10.2026 | 👁️GURU.Markets👁️")
ANI Pharmaceuticals (ANIP) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati ANI Pharmaceuticals|ANIP - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati anipharmaceuticals.com|ANIP - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati ANI Pharmaceuticals, Inc.|ANIP - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz ANI Pharmaceuticals|Oraliq likvidlik koeffitsiyenti anipharmaceuticals.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:ANI Pharmaceuticals Inc - ANIP
Investorlar ANI Pharmaceuticals (ANIP) kompaniyasining barqarorligini bir yildan ortiq muddatli kredit majburiyatlarining aksiyadorlar kapitaliga nisbatini o'lchovchi uzoq muddatli leverajni tahlil qilish orqali baholamoqdalar. Uzoq muddatli qarzning kapitalga nisbati tendentsiyasi generik portfeli kritik qarz yuklarisiz kengayishni qanchalik samarali moliyalashtirayotganini ko'rsatadi hamda moliyaviy leveraj va emitentning to'lov qobiliyati o'rtasidagi muvozanatni belgilaydi.
Raqobatdosh kompaniyalar tahlili
Haleon PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KVUE|VRNA (Verona Pharma Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MENS (Jyong Biotech Ltd)|Uzoq muddatli qarzning kapitalga nisbati ligand.com LGND|AMRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Liquidia Inc.|GLPG (Galapagos NV) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati mannkindcorp.com|Uzoq muddatli qarzning o'z kapitaliga nisbati AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ARS Pharma SPRY|Theravance Corp (TBPH) - Uzoq muddatli majburiyatlarning kapitalga nisbati|AQST: Uzoq muddatli qarzning o'z kapitaliga nisbati|scPharmaceuticals Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|TECX: Uzoq muddatli qarzning kapitalga nisbati|Tonix Pharma - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SXTC (SXT Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Eupraxia Pharma EPRX|Uzoq muddatli qarzning o'z kapitaliga nisbati BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ORMP (Oramed Pharmaceuticals Inc.)|Uzoq muddatli qarzning kapitalga nisbati Entera Bio Ltd ENTX|HYFT - Uzoq muddatli qarzning o'z kapitaliga nisbati|ABVC (ABVC BioPharma, Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|CPIX: Uzoq muddatli qarzning kapitalga nisbati|QNTM - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati FGEN|TELO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Rani Therapeutics (RANI)|SNYR: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLYB (Rallybio)|Uzoq muddatli qarzning kapitalga koeffitsiyenti LEXX|Pulmatrix - Uzoq muddatli qarzning kapitalga nisbati|PTHL - Uzoq muddatli qarzning kapitalga nisbati|aptorumgroup.com (APM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Lyra Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Impact BioMedical Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati TNF Pharma (TNFA)|Uzoq muddatli qarzning kapitalga nisbati YCBD|Uzoq muddatli qarzning kapitalga nisbati PainReform Ltd (PRFX)|Uzoq muddatli qarzning kapitalga nisbati CYTO (Altamira Therapeutics Ltd.)|LIPO - Uzoq muddatli qarzning o'z kapitaliga nisbati|OptiNose, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati pieris.com|PROC (Procaps) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Petros Pharmaceuticals Inc (PTPI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati QLI|SLRN (ACELYRIN Inc.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati TFFP